GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
22 hedge funds and large institutions have $4.71M invested in Amplify Treatments, Testing and Advancements ETF in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$230K | |
| 2 | +$110K | |
| 3 | +$55.4K | |
| 4 |
LPL Financial
San Diego,
California
|
+$44.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$23.9K |
Top Sellers
| 1 | -$274K | |
| 2 | -$36.7K | |
| 3 | -$36.4K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$15.8K |
| 5 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
-$5K |